Status:
UNKNOWN
Effect of FFRCT-angio in Functional Diagnosis of Coronary Artery Stenosis
Lead Sponsor:
First Affiliated Hospital of Harbin Medical University
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-90 years
Brief Summary
Coronary CT angiography (CTA) or invasive coronary angiography (CAG) is usually performed to evaluate the severity of coronary stenosis depending on the probability of CAD. However, the stenosis sever...
Detailed Description
Cardiovascular disease remains the leading cause of death worldwide, and stable coronary artery disease (SCAD) accounts for the greatest proportion of cardiovascular disease. In the past decades, perc...
Eligibility Criteria
Inclusion
- Patients with stable coronary heart disease undergoing CTA.
- Patients with at least one coronary artery stenosis of 50% - 90% in diameter ≥ 2mm.
- Within 30 days after CTA, CAG and FFR were determined by clinicians according to their condition.
Exclusion
- Patients with myocardial infarction within 72 hours.
- Patients with coronary artery thrombosis.
- Patients with a history of allergy to contrast media or adenosine.
- NYHA class III-IV patients.
- Patients with previous CABG, target vessel PCI, pacemaker, ICD.
- Patients with a history of prosthetic valve implantation.
- Patients with myocardial bridges in the target vessels.
- Patients with severe arrhythmia.
Key Trial Info
Start Date :
October 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04493086
Start Date
October 1 2020
End Date
December 31 2021
Last Update
July 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the first affiliated hospital of Harbin medical university
Harbin, Heilongjiang, China, 150001